Literature DB >> 29241236

Diving and antidepressants.

Abraham L Querido1.   

Abstract

Psychoactive drugs pose a risk to both the diver and his or her buddy. Little is known about the safety of diving with antidepressants. Amongst the potential interactions with the diving environment are: somnolence; convulsions; a bleeding tendency (potentially worsening decompression illness, DCI), alterations to glucose metabolism and psychiatric side effects. Fluoxetine may potentially reduce the inflammatory process associated with DCI. This article presents guidelines for recreational diving in combination with antidepressants. These guidelines were endorsed at a meeting of the Dutch Association for Diving Medicine in 2015 and are solely based on 'expert' opinion. Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in printed and other forms.

Entities:  

Keywords:  Diving medicine; Fitness to dive; Medications; Recreational diving; Review article; Side effects

Mesh:

Substances:

Year:  2017        PMID: 29241236      PMCID: PMC6708605          DOI: 10.28920/dhm47.4.253-256

Source DB:  PubMed          Journal:  Diving Hyperb Med        ISSN: 1833-3516            Impact factor:   0.887


  23 in total

Review 1.  Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis.

Authors:  Hai-Yin Jiang; Hua-Zhong Chen; Xin-Jun Hu; Zheng-He Yu; Wei Yang; Min Deng; Yong-Hua Zhang; Bing Ruan
Journal:  Clin Gastroenterol Hepatol       Date:  2014-06-30       Impact factor: 11.382

Review 2.  Antidepressants and seizures: emphasis on newer agents and clinical implications.

Authors:  S A Montgomery
Journal:  Int J Clin Pract       Date:  2005-12       Impact factor: 2.503

3.  Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case-Control Analysis Using the Clinical Practice Research Datalink.

Authors:  Marlene Bloechliger; Alessandro Ceschi; Stephan Rüegg; Hugo Kupferschmidt; Stephan Kraehenbuehl; Susan S Jick; Christoph R Meier; Michael Bodmer
Journal:  Drug Saf       Date:  2016-04       Impact factor: 5.606

Review 4.  Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: a review.

Authors:  Ross J Baldessarini; Gianni L Faedda; Emanuela Offidani; Gustavo H Vázquez; Ciro Marangoni; Giulia Serra; Leonardo Tondo
Journal:  J Affect Disord       Date:  2012-12-06       Impact factor: 4.839

5.  Stimulatory effect of antidepressants on the production of IL-6.

Authors:  Marta Kubera; Gunter Kenis; Eugene Bosmans; Małgorzata Kajta; Agnieszka Basta-Kaim; Simon Scharpe; Bogusława Budziszewska; Michael Maes
Journal:  Int Immunopharmacol       Date:  2004-02       Impact factor: 4.932

6.  Three-year medication prophylaxis in panic disorder: to continue or discontinue? A naturalistic study.

Authors:  Yujuan Choy; Eric D Peselow; Brady G Case; Mary Ann Pressman; Jamie A Luff; Gonzalo Laje; Mary Paizis; Patrick Ying; Mary T Guardino
Journal:  Compr Psychiatry       Date:  2007-07-05       Impact factor: 3.735

7.  The effects of hyperbaric air and hyperbaric oxygen on blood-brain barrier integrity in rats.

Authors:  Nihal Gunes Cevik; Nurcan Orhan; Canan Ugur Yilmaz; Nadir Arican; Bulent Ahishali; Mutlu Kucuk; Mehmet Kaya; Akin Savas Toklu
Journal:  Brain Res       Date:  2013-08-03       Impact factor: 3.252

8.  Suicidality in pediatric patients treated with antidepressant drugs.

Authors:  Tarek A Hammad; Thomas Laughren; Judith Racoosin
Journal:  Arch Gen Psychiatry       Date:  2006-03

9.  Fluoxetine stimulates anti-inflammatory IL-10 cytokine production and attenuates sensory deficits in a rat model of decompression sickness.

Authors:  Jean-Eric Blatteau; Sébastien de Maistre; Kate Lambrechts; Jacques Abraini; Jean-Jacques Risso; Nicolas Vallée
Journal:  J Appl Physiol (1985)       Date:  2015-10-22

10.  Protective effects of fluoxetine on decompression sickness in mice.

Authors:  Jean-Eric Blatteau; Sandrine Barre; Aurelie Pascual; Olivier Castagna; Jacques H Abraini; Jean-Jacques Risso; Nicolas Vallee
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

View more
  1 in total

1.  Regular medication use by active scuba divers with a declared comorbid medical condition and victims of scuba and snorkelling-related fatalities.

Authors:  Simone E Taylor; David M Taylor; Daisy Pisasale; Kyle Booth; John Lippmann
Journal:  Diving Hyperb Med       Date:  2021-09-30       Impact factor: 1.228

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.